ALL FOR ONE GROUP NA O.N./ DE0005110001 /
14.06.2024 8:01:25 | Изменение +0.20 | Объем сделки | Бид13:17:25 | Предложение13:17:25 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
61.20EUR | +0.33% | 0 Оборот: 0.00 |
60.60Величина цены спроса: 50 | 61.60Величина цены предложения: 50 | 301.91 млнEUR | 2.39% | 22.61 |
GlobeNewswire
13:30
JOYY Inc. Announces the Results of the Repurchase Right Offer for its 1.375% Convertible Senior Note...
GlobeNewswire
13:30
Cogent Biosciences Announces Additional Clinical Data from Part 1 of its Ongoing SUMMIT Trial Evalua...
GlobeNewswire
13:30
Phase 2 Findings Show Wugen’s Investigational Allogeneic CAR-T, WU-CART-007, Was Highly Effective an...
GlobeNewswire
13:30
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Associatio...
GlobeNewswire
13:30
Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Associatio...
GlobeNewswire
13:14
Hymson Brings its Laser Solutions for Battery Innovation to The Battery Show Europe 2024
GlobeNewswire
13:01
Invivyd Announces Antiviral Activity of VYD222 (pemivibart) Against SARS-CoV-2 KP.1.1 FLiRT & KP.3 V...
GlobeNewswire
13:00
Correction: 仙境传说:破晓 (Ragnarok: Dawn, Tentative English Title) Received an ISBN from the Chinese Gove...
GlobeNewswire
13:00
Kymera Therapeutics Presents New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-3...
GlobeNewswire
13:00
Volvo Car Canada Collaborates with iconic global fashion brand to unveil curated looks inspired by t...
GlobeNewswire
13:00
Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Second Quarter ...
GlobeNewswire
13:00
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in ...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница